Beijing Hotgen Biotech Co., Ltd. (688068.SS)
CNY 52.76
(-1.59%)
CNY 52.76
(-1.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -51.94 Million | 978.75 Million | 2.64 Billion | 164.62 Million | 19.37 Million | 55.03 Million |
| Net Income | 15.05 Million | 925.11 Million | 2.2 Billion | 111.29 Million | 33.74 Million | 48.18 Million |
| Depreciation & Amortization | 70.52 Million | 120.29 Million | 68.34 Million | 29.14 Million | 21.97 Million | 16.61 Million |
| Deferred income taxes | -4.57 Million | -17.92 Million | -10.39 Million | -736.54 Thousand | -604.82 Thousand | 467.2 Thousand |
| Stock-based compensation | 4 Million | 7.19 Million | 8.46 Million | 4.29 Million | 2.16 Million | - |
| Change in working capital | -73.31 Million | -247.16 Million | 259.42 Million | 16.8 Million | -46.58 Million | -15.58 Million |
| Other non-cash items | -17.6 Million | 191.23 Million | 116.27 Million | 3.81 Million | 8.66 Million | 5.82 Million |
| Investing Cash Flow | -161.86 Million | -1.13 Billion | -1.76 Billion | -164.09 Million | -85.85 Million | -40.57 Million |
| Investments in PPE | -413.35 Million | -565.21 Million | -398.86 Million | -172.26 Million | -88.48 Million | -42 Million |
| Acquisitions | -9.87 Million | 8.81 Million | 133.45 Thousand | 172.31 Million | 88.48 Million | - |
| Investment purchases | -826.16 Million | -2.65 Billion | -4.9 Billion | -1.69 Billion | -412.8 Million | -100 Million |
| Sales/Maturities of investments | 1.09 Billion | 2.07 Billion | 3.56 Billion | 1.69 Billion | 415.42 Million | 101.02 Million |
| Other Investing Activities | -17.42 Million | 11.68 Million | -19.99 Million | -172.26 Million | -88.48 Million | 403.92 Thousand |
| Financing Cash Flow | -36.54 Million | -484.98 Million | -95.06 Million | -42.16 Million | 425.43 Million | 437.87 Thousand |
| Debt repayment | -27.24 Million | -32.28 Million | -11.4 Million | -23.75 Million | -1.25 Million | -158.85 Thousand |
| Dividends payments | - | -310.98 Million | -93.29 Million | -18.65 Million | -1.03 Million | -3275.87 |
| Common Stock Repurchased | -16.44 Million | -150.03 Million | - | - | 15.69 Million | - |
| Common Stock Issuance | - | 182.32 Million | - | - | -15.69 Million | - |
| Other Financing Activities | -36.54 Million | -174 Million | 9.62 Million | 692.33 Thousand | 427.72 Million | 599.99 Thousand |
| Accounts receivables | 92.84 Million | -22.27 Million | -81.51 Million | -19.86 Million | -25.65 Million | -10.98 Million |
| Accounts payables | -285.09 Million | -242.98 Million | 564.77 Million | 97.54 Million | 15.56 Million | 3.36 Million |
| Inventory | 123.51 Million | 36.03 Million | -213.43 Million | -60.13 Million | -35.88 Million | -8.43 Million |
| Other working capital | -71.27 Million | -17.92 Million | -10.39 Million | -736.54 Thousand | -604.82 Thousand | -7.14 Million |
| Cash at beginning of period | 523.21 Million | 1.15 Billion | 382.61 Million | 422.84 Million | 63.76 Million | 48.59 Million |
| Cash at end of period | 272.38 Million | 523.21 Million | 1.15 Billion | 382.61 Million | 422.84 Million | 63.76 Million |
| Capital Expenditure | -413.35 Million | -565.21 Million | -398.86 Million | -172.26 Million | -88.48 Million | -42 Million |
| Effect of forex changes on cash | -464.79 Thousand | 5.19 Million | -14.83 Million | 1.4 Million | 126.95 Thousand | 271.76 Thousand |
| Net cash flow / Change in cash | -250.82 Million | -631.08 Million | 771.68 Million | -40.23 Million | 359.07 Million | 15.16 Million |
| Free Cash Flow | -465.3 Million | 413.54 Million | 2.24 Billion | -7.64 Million | -69.11 Million | 13.03 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.82 Million | -48.52 Million | 5.05 Million | -26.99 Million | 15.05 Million | -30.38 Million |
| Depreciation & Amortization | - | 25.22 Million | 25.22 Million | 70.52 Million | 70.52 Million | -30.8 Million |
| Deferred income taxes | - | - | - | - | -4.57 Million | 63.11 Million |
| Stock-based compensation | - | 1.73 Million | - | 4 Million | 4 Million | -2.02 Million |
| Change in working capital | - | -21.4 Million | - | 145.08 Million | -73.31 Million | -42.76 Million |
| Other non-cash items | -8.35 Million | 83.98 Million | -19.06 Million | 110.78 Million | -17.6 Million | -108.96 Million |
| Investing Cash Flow | -76.74 Million | -113.26 Million | 63.26 Million | -190.43 Million | -161.86 Million | 16.48 Million |
| Investments in PPE | -20.56 Million | 6.78 Million | -40.5 Million | -184.49 Million | -413.35 Million | 48.94 Million |
| Acquisitions | -2.91 Million | 5.01 Million | - | -13.67 Million | -9.87 Million | - |
| Investment purchases | -83.31 Million | -87.99 Million | -86.89 Million | -134.87 Million | -826.16 Million | -183 Million |
| Sales/Maturities of investments | 29.74 Million | -36.1 Million | 190.68 Million | 135.52 Million | 1.09 Billion | 140.2 Million |
| Other Investing Activities | 305.81 Thousand | 15.43 Thousand | -15.43 Thousand | -10.34 Million | -17.42 Million | 10.34 Million |
| Financing Cash Flow | 36.08 Million | -16.49 Million | -86.96 Million | -27.24 Million | -36.54 Million | 512.49 Thousand |
| Debt repayment | - | - | - | - | -27.24 Million | - |
| Dividends payments | - | -12.16 Million | - | - | - | - |
| Common Stock Repurchased | 92.02 Million | -92.02 Million | - | -16.44 Million | -16.44 Million | 16.44 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -55.94 Million | -4.32 Million | -86.96 Million | -27.24 Million | -36.54 Million | -15.93 Million |
| Accounts receivables | - | -41.57 Million | - | 92.84 Million | 92.84 Million | 20.26 Million |
| Accounts payables | - | - | - | - | -285.09 Million | -41.06 Million |
| Inventory | - | 32.03 Million | - | 123.51 Million | 123.51 Million | -63.03 Million |
| Other working capital | - | -11.86 Million | - | -71.27 Million | -71.27 Million | 41.06 Million |
| Cash at beginning of period | 118.52 Million | 234.6 Million | 272.38 Million | 194.1 Million | 523.21 Million | 325.59 Million |
| Cash at end of period | 72.74 Million | 118.51 Million | 234.6 Million | 272.38 Million | 272.38 Million | 194.1 Million |
| Capital Expenditure | -20.56 Million | 6.78 Million | -40.5 Million | -184.49 Million | -413.35 Million | 48.94 Million |
| Effect of forex changes on cash | - | -214.28 Thousand | -78.2 Thousand | -3.43 Million | -464.79 Thousand | 3.33 Million |
| Net cash flow / Change in cash | -45.78 Million | -116.08 Million | -37.78 Million | 78.28 Million | -250.82 Million | -131.49 Million |
| Free Cash Flow | -26.08 Million | 17.03 Million | -54.51 Million | 114.9 Million | -465.3 Million | -102.88 Million |
CPLE5
600339
VNORP
LOT
TOPP
MSGCF